Isak Buitendag13 Sep 2021 09:03
RNS today - new CEO.
Don't let the horses run just yet, though.
Appointment date is 15th Nov, so we still need to know what the plan / funding etc. is going forward. An update on on progress here as well as the plant situation is crucial. Will the new man (can the new man) be involved prior to November? Probably not!
$400k seems cheap IMO, so is the real value in his incentives? Some are shown with three tranches of 2.5m performance rights (shares?) which all look good at current face value. Assuming he has accepted this, then it would imply some basis for funding going forward is known. i.e. if there is to be massive dilution, then these performance rights are not so valuable.
If there is to be a predatory cost for funding via loans etc, then P&L will be harmed. These incentives have production date triggers, not P&L constraints. However the cost and P&L will have an affect on value.
So no real clues here.
Funding, Plant and production are key, more so than whoever picks up the reins in November (presumably after which most of the decisions have been made).
Still watching and waiting here. IMO starting gun fired, but nobody has left the blocks yet.